Procter & Gamble director receives 236 RSUs; dividend equivalents included
Rhea-AI Filing Summary
Christine M. McCarthy, a director of Procter & Gamble Co. (PG), reports a grant of 236 Restricted Stock Units (RSUs) on 09/09/2025 under the Procter & Gamble 2019 Stock & Incentive Compensation Plan. The RSUs were granted with a reported price of $0 and include dividend equivalents converted into additional RSUs. Following the grant, Ms. McCarthy beneficially owns 14,946.5131 shares (reported as direct ownership). The filing is signed by an attorney-in-fact on 09/10/2025 and includes the plan-based award disclosure in the explanatory notes.
Positive
- Director compensation aligned with shareholders through RSUs that vest with service, promoting long-term alignment
- Dividend equivalents included as RSUs preserve value and mirror shareholder returns
Negative
- None.
Insights
TL;DR: Routine director equity grant; aligns compensation with shareholder interests without immediate cash cost.
The reported transaction is a standard form of director compensation: 236 RSUs awarded under the company equity plan. RSUs granted at a $0 price indicate a service-based award rather than a purchase; dividend equivalents were converted into additional RSUs, modestly increasing the total reported beneficial ownership to 14,946.5131 shares. For governance review, this is a typical equity alignment mechanism and raises no immediate liquidity or dilution concern beyond routine plan authorizations.
TL;DR: Non-material stock-based award; unlikely to affect near-term valuation or trading.
From a market-impact perspective, a grant of 236 RSUs to a director is immaterial relative to P&G’s market capitalization. The form shows direct beneficial ownership and inclusion of dividend equivalents, consistent with common practices to preserve value for long-term alignment. There is no exercise price or sale reported, so no immediate share issuance or proceeds are associated with this filing.